Aurobindo Pharma reports 40% rise in Q1 consolidated net profit

08 Aug 2019 Evaluate

Aurobindo Pharma has reported results for first quarter ended June 30, 2019.

The company has reported a rise of 46.81% in its net profit at Rs 330.50 crore for the quarter under review as compared to Rs 225.12 crore for the same quarter in the previous year. Total income of the company increased by 21.37% at Rs 3,108.97 crore for Q1FY20 as compared Rs 2,561.64 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 39.53% in its net profit at Rs 635.68 crore for the quarter under review as compared to Rs 455.59 crore for the same quarter in the previous year. Total income of the company increased by 27.16% at Rs 5,460.38 crore for Q1FY20 as compared Rs 4294.00 crore for the corresponding quarter previous year.

Aurobindo Pharma Share Price

1089.45 19.45 (1.82%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.